Insulin action and hepatic glucose cycling in Cushing's syndrome

被引:14
作者
Heaney, AP
Harper, R
Ennis, C
Rooney, DP
Sheridan, B
Atkinson, AB
Bell, PM
机构
[1] ROYAL VICTORIA HOSP, SIR GEORGE E CLARK METAB UNIT, BELFAST BT12 6BA, ANTRIM, NORTH IRELAND
[2] ROYAL VICTORIA HOSP, REG ENDOCRINE LAB, BELFAST BT12 6BA, ANTRIM, NORTH IRELAND
关键词
D O I
10.1046/j.1365-2265.1997.2121024.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Although it is well established hypercortisolism causes insulin resistance, mechanisms responsible for impaired insulin action in Cushing's syndrome are unclear. This study investigated the contribution of the glucose/glucose-6-phosphate substrate cycle (G/G6P). PATIENTS Eight patients with Cushing's syndrome and seven control subjects were studied. All had normal fasting plasma glucose. DESIGN Insulin action was assessed using the euglycaemic glucose clamp at insulin infusion rates of 0.4 and 2.0 mU/kg/min combined with a simultaneous infusion of [2(3)H]- and [6(3)-H]-glucose. Glucose/glucose-6-phosphate cycle activity was calculated as the difference in glucose turnover rates determined separately for [2(3)H]- and [6(3)H]-glucose by selective enzymatic detritiation. MEASUREMENTS AND RESULTS Exogenous glucose infusion rates required to maintain euglycaemia were significantly lower in Cushing's patients compared to controls, during the 0.4 mU/kg/min (7.8 +/- 1.2 vs 15.7 +/- 0.5 mu mol/kg/min, P<0.001) and the 2.0 mU/kg/min insulin infusions (26.2 +/- 2.8 vs 51.5 +/- 3.5 mu mol/kg/min, P<0.001). Endogenous glucose production was similar in both groups in the postabsorptive state (10.2 +/- 0.3 vs 10.8 +/- 0.4 mu mol/kg/min, P = 0.50) and suppressed to a similar degree during hyperinsulinaemia. G/G6P cycle activity was markedly increased in the Cushing's group in the postabsorptive state (5.4 +/- 1.1 vs 2.0 +/- 0.5 mu mol/kg/min, P = 0.028) and during the 0.4 mU/kg/min (3.2 +/- 0 6 vs 1.2 +/- 0.4 mu mol/kg/min, P = 0.014) and 2.0 mU/kg/min insulin infusions (3.3 +/- 0.8 vs 1.1 +/- 0.5 mu mol/kg/min, P = 0.049). CONCLUSIONS Patients with Cushing's syndrome show marked peripheral insulin resistance and enhanced hepatic G/G6P cycle activity. In the fasting state increased glucose/glucose-6-phosphate cycle activity may be a protective mechanism limiting hyperglycaemia. During hyperinsulinaemia G/G6P cycle activity was increased but insulin resistance was predominantly due to reduced peripheral glucose uptake.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 37 条
[21]  
KNUTSON VP, 1986, J BIOL CHEM, V261, P306
[22]   HORMONAL-REGULATION OF HEPATIC GLUCONEOGENESIS [J].
KRAUSFRIEDMANN, N .
PHYSIOLOGICAL REVIEWS, 1984, 64 (01) :170-259
[23]   EFFECTS OF GLUCOCORTICOIDS ON CARBOHYDRATE-METABOLISM [J].
MCMAHON, M ;
GERICH, J ;
RIZZA, R .
DIABETES-METABOLISM REVIEWS, 1988, 4 (01) :17-30
[24]   INFLUENCE OF GROWTH-HORMONE ON GLUCOSE-GLUCOSE 6-PHOSPHATE CYCLE AND INSULIN ACTION IN NORMAL HUMANS [J].
NEELY, RDG ;
ROONEY, DP ;
BELL, PM ;
BELL, NP ;
SHERIDAN, B ;
ATKINSON, AB ;
TRIMBLE, ER .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (05) :E980-E987
[25]   EVIDENCE FOR SUPPRESSION OF HEPATIC GLUCOSE-6-PHOSPHATASE WITH CARBOHYDRATE FEEDING [J].
NEWGARD, CB ;
FOSTER, DW ;
MCGARRY, JD .
DIABETES, 1984, 33 (02) :192-195
[26]   INSULIN RESISTANCE IN CUSHINGS-SYNDROME [J].
NOSADINI, R ;
DELPRATO, S ;
TIENGO, A ;
VALERIO, A ;
MUGGEO, M ;
OPOCHER, G ;
MANTERO, F ;
DUNER, E ;
MARESCOTTI, C ;
MOLLO, F ;
BELLONI, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (03) :529-536
[27]   EFFECTS OF ACUTE AND CHRONIC DEXAMETHASONE ADMINISTRATION ON INSULIN BINDING TO ISOLATED RAT HEPATOCYTES AND ADIPOCYTES [J].
OLEFSKY, JM ;
JOHNSON, J ;
LIU, F ;
JEN, P ;
REAVEN, GM .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (04) :517-527
[28]   EFFECTS OF GLUCOCORTICOIDS ON CARBOHYDRATE-METABOLISM [J].
OLEFSKY, JM ;
KIMMERLING, G .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1976, 271 (02) :202-210
[29]   INSULIN-SECRETION, INSULIN SENSITIVITY AND GLUCOSE-MEDIATED GLUCOSE DISPOSAL IN CUSHINGS-DISEASE - A MINIMAL MODEL ANALYSIS [J].
PAGE, R ;
BOOLELL, M ;
KALFAS, A ;
SAWYER, S ;
PESTELL, R ;
WARD, G ;
ALFORD, F .
CLINICAL ENDOCRINOLOGY, 1991, 35 (06) :509-517
[30]  
REICHARD GA, 1963, J BIOL CHEM, V238, P495